References and Notes
1
Inouye S.
Tsuruoka T.
Nida T.
J.
Antibiot.
1966,
19:
288
2
Borges de Melo E.
da Silveira Gomes A.
Carvalho I.
Tetrahedron
2006,
62:
10277
3
Suganuma R.
Walden CM.
Butters TD.
Platt FM.
Dwek RA.
Yanagimachi R.
Van der Spoel AC.
Biol. Reprod.
2005,
72:
805
4
Zou W.
Curr.
Top. Med. Chem.
2005,
5:
1363
5
Iminosugars: From Synthesis
to Therapeutic Applications
Compain P.
Martin OR.
John Wiley
and Sons, Ltd.;
Chichester:
2007.
6
McDonnell C.
Cronin L.
O′Brien JL.
Murphy PV.
J.
Org. Chem.
2004,
69:
3565
7
Songa X.
Hollingsworth RI.
Tetrahedron
Lett.
2007,
48:
3115
8
La Ferla BL.
Bugada P.
Cipolla L.
Peri F.
Nicotra F.
Eur.
J. Org. Chem.
2004,
2451
9
Myers WH.
Robertson GJ.
J. Am. Chem. Soc.
1943,
65:
8
10
Jones JKN.
Szarek WA.
Can.
J. Chem.
1963,
41:
636
11
Hanessian S.
Haskell TH.
J. Org. Chem.
1963,
28:
2604
12
Paulsen H.
Angew.
Chem., Int. Ed. Engl.
1966,
5:
495
13
Behr J.-B.
Plantier-Royon R.
Recent Res. Dev. Org.
Chem.
2006,
10:
23
14
Afarinkia K.
Bahar A.
Tetrahedron: Asymmetry
2005,
16:
1239
15
Ruiz M.
Ruanova TM.
Blanco O.
Nunez F.
Pato C.
Ojea V.
J. Org. Chem.
2008,
73:
2240
16
Aguilar M.
Diaz-Perez P.
Garcia-Moreno MI.
Ortiz Mellet C.
Garcia Fernandez JM.
J.
Org. Chem.
2008,
73:
1995 ;
and references cited therein
17
Takahashi H.
Shida T.
Hitomi Y.
Iwai Y.
Miyama N.
Nishiyama K.
Sawada D.
Ikegami S.
Chem. Eur. J.
2006,
12:
5868
18
Joseph CC.
Regeling H.
Zwanenburg B.
Chittenden
GJF.
Carbohydr.
Res.
2002,
337:
1083
19
Pandey G.
Bharadwaj KC.
Khan MI.
Shashidhara
KS.
Puranik VG.
Org. Biomol. Chem.
2008,
6:
2587
20
Pearson MSM.
Mathé-Allainmat M.
Fargeas V.
Lebreton J.
Eur.
J. Org. Chem.
2005,
2159
21
Shitara E.
Nishimura Y.
Kojima F.
Takeuchi T.
Bioorg. Med. Chem.
2000,
8:
343
22
Bussiere A.
Barragan-Montero V.
Toupet L.
Clavel C.
Montero J.-L.
Lett.
Org. Chem.
2006,
3:
654
23
Wasserman HH.
Petersen AK.
Tetrahedron Lett.
1997,
38:
953 ; and references cited therein
24
Synthesis of Compound
2
To a solution of 2,3:4,6-Di-O-isopropylidene-d-manno-pyranose (1 equiv, 23 mmol, 6 g)
in anhyd benzene was added(cyanomethylene) triphenylphosphorane
(3 equiv, 69 mmol, 21 g). The mixture was stirred and refluxed under argon
atmosphere for 3 h. The reaction mixture was diluted with CH2Cl2 (200
mL) and washed twice with brine (50 mL). The organic layer was dried
over anhyd Na2SO4 for 30 min and concentrated
under vacuum to give pale yellowish oil. The crude was chromatographed
on SiO2 (PE-Et2O, 5:5) to afford
the two isomers (6.5 g, 70% for Z-isomer)
as colorless oils. R
f
= 0.16
(Z-isomer, major), 0.08 (E-isomer, minor; PE-Et2O,
5:5). ¹H NMR (400 MHz, acetone-d
6):
δ (Z-isomer) = 6.81 (dd, J
1-7 = 11.26
Hz, J
1-2 = 8.00
Hz, H1), 5.77 (dd, J
7-1 = 11.27
Hz, J
7-2 = 1.30
Hz, H7), 5.16 (dt,
J
2-1 = 7.85
Hz, J
2-3 = 7.80
Hz, J
2-7 = 1.27
Hz, H2), 4.72 (dd, J
3-2 = 7.48
Hz, J
3-4 = 1.45
Hz, H3), 4.29 (d, J
OH-5 = 6.01
Hz, -OH), 3.81-3.70 (m, H5, H6a),
3.58 (dd, J = 10.16,
9.07 Hz, H6a), 3.48 (dd, J
4-5 = 9.17
Hz, J
4-3 = 1.43
Hz, H4), 1.48, 1.41, 1.37, 1.31 (4 s, 12 H, H10,
H11, H13, H14). ¹³C
NMR (100 MHz, acetone-d
6): δ (Z-isomer) = 153.45 (C1),
117.16 (C8), 111.70 (C9), 102.34 (C7),
99.90 (C12), 77.87 (C2), 77.64 (C3), 74.44
(C4), 66.48 (C6), 63.94 (C5), 30.09,
27.90, 26.89, 19.96 (C10, C11, C13,
C14). MS (ESI+): m/z = 306.22 [M + Na]+.
25
Nicotra F.
Ronchetti F.
Russo G.
Toma L.
Tetrahedron Lett.
1984,
25:
5697
26
Das B.
Chowdhury N.
J. Mol. Catal. A.: Chem.
2007,
263:
212
27
Surendra K.
Krishnaveni NS.
Sridhar R.
Rao KR.
Tetrahedron Lett.
2006,
47:
2125
28
Duan Z.
Xuan X.
Li T.
Yang C.
Wu Y.
Tetrahedron Lett.
2006,
47:
5433
29
Hussain S.
Bharadwaj SK.
Chaudhuri MK.
Kalita H.
Eur. J. Org.
Chem.
2007,
374
30
Yang J.-M.
Ji S.-J.
Gu D.-G.
Shen Z.-L.
Wang S.-Y.
J.
Organomet. Chem.
2005,
690:
2989
31
Typical Procedure
for the Synthesis of Compounds 3-5
Compound 2 (1 equiv) was dissolved in dry amine
in excess. The mixture was placed in an ultrasound bath under an
argon atmosphere for 10 h. The unreacted amine was removed under
reduced pressure and the byproducts removed by flash chromatography
on SiO2 (PE-Et2O, 8:2) to afford compounds 3, 4, or 5 as colorless oils in 80% yield.
Compound 3: R
f
= 0.11
(PE-Et2O, 8:2). ¹H NMR (400
MHz, acetone-d
6): δ = 7.46-7.19
(m, 5 H, Hc, Hd, He), 4.48 (dd,
J
3-2 = 6.29
Hz, J
3-4 = 1.55
Hz, H3), 4.28 (dd, J
2-1 = 8.85
Hz, J
2-3 = 6.29
Hz, H2), 4.22 (d, J
OH-5 = 5.88
Hz, OH), ν0 = 3.82 (ABq,
2 H, νA = 4.03, νB = 3.87, Δν = 64.2
Hz, J
AB = 14.0 Hz,
Ha), 3.79-3.68 (m, H5, H6a),
3.63-3.50 (m, H6b), 3.61 (dd, J
4-5 = 8.93
Hz, J
4-3 = 1.57
Hz, H4), 3.33 (ddd, J
1-2 = 8.92 Hz, J
1-7b = 5.18
Hz, J
1-7a = 4.49
Hz, H1), 2.81 (dd, J
7a-7b = 17.39
Hz, J
7a-1 = 4.44
Hz, H7a) 2.58 (dd, J
7b-7a = 17.40 Hz, J
7b-1 = 5.29
Hz, H7b), 1.48, 1.33, 1.23, 1.20 (4 s, 12 H, H10, H11,
H13, H14). ¹³C
NMR (100 MHz, acetone-d
6): δ = 142.55 (Cb),
130.07 and 129.87 (2 C, Cc, Cd), 128.55 (Ce),
119.67 (C8), 110.31 (C9), 99.82 (C12),
80.65 (C2), 75.79 (C3), 74.44 (C4),
66.48 (C6), 63.92 (C5), 53.73 (C1),
52.16 (Ca), 29.98, 27.75, 27.20, 20.03 (4C, C10,
C11, C13, C14), 22.03 (C7).
MS (ESI+): m/z = 391.13 [M + H]+,
413.13 [M + Na]+.
MS (ESI-): m/z = 425.46 [M + Cl]-.
Compound 4: R
f
= 0.28
(Et2O). ¹H NMR (400 MHz, acetone-d
6): δ = 4.48
(dd, J
3-2 = 6.26
Hz, J
3-4 = 1.56
Hz, H3), 4.20 (dd, J
2-1 = 8.53
Hz, J
2-3 = 6.26
Hz, H2), 3.84-3.67 (m, H4, H5,
H6a), 3.64-3.56 (m, H6b), 3.28 (ddd, J
1-2 = 8.52
Hz, J
1-7b = 5.54
Hz, J
1-7a = 4.52
Hz, H1), 2.73 (dd, J
7a-7b = 17.31 Hz, J
7a-1 = 4.53
Hz, H7a), 2.55 (dd, J
7b-7a = 17.32
Hz, J
7b-1 = 5.54
Hz, H7b), 2.78-2.70 (m, H9a), 2.68-2.61
(m, H9b), 1.49-1.32 (m, H10, H11),
1.50, 1.48, 1.33, 1,32 (4 s, 12 H, H14, H15, H17,
H18), 0.91 (t, J
12-11a = 7.20, J
12-11b = 7.20
Hz, H12). ¹³C NMR (100 MHz,
acetone-d
6): δ = 119.83
(C8), 110.15 (C13), 99.91 (C16),
80.26 (C2), 75.83 (C3), 74.45 (C4),
66.57 (C6), 64.07 (C5), 55.36 (C1),
48.30 (C9), 34.09 (C10), 30.15, 27.75, 27.13,
20.45 (4 C, C14, C15, C17, C18),
21.95 (C11), 15.25 (C12). MS (ESI+): m/z = 357.31 [M + H]+,
379.33 [M + Na]+. MS
(ESI-): m/z = 355.36 [M - H]-,
391.28
[M + Cl]-.
Compound 5: R
f
= 0.08
(PE-Et2O, 9:1). ¹H NMR (400
MHz, acetone-d
6): δ = 5.90
(dddd, J
10-11
trans
= 17.29
Hz, J
10-11
cis
= 10.33 Hz, J = 6.15 Hz, J = 5.19 Hz,
H10), 5.25 (qd, J
11
trans
-10 = 17.29
Hz, J = 1.80,
1.80, 1.79 Hz, H11
trans
),
5.08 (ddd, J
11
cis
-10 = 10.34
Hz, J = 3.42
Hz, J = 1.48
Hz, H11
cis
), 4.48
(dd,
J
3-2 = 6.28
Hz, J = 1.57
Hz, H3), 4.24 (dd, J = 8.68
Hz, J
2-3 = 6.27
Hz, H2), 3.82-3.55 (m, 4 H, H4, H5,
H6a, H6b), 3.47-3.29 (m, 3 H, H1,
H9a, H9b), 2.75 (dd, J
7a-7b = 17.35
Hz, J = 4.49 Hz,
H7a), 2.55 (dd, J
7b-7a = 17.35
Hz, J = 5.41
Hz, H7b), 1.48, 1.32 (2 d, 12 H, H13, H14,
H16, H17). ¹³C
NMR (100 MHz, acetone-d
6): δ = 139.48
(C10), 119.76 (C8), 116.70 (C11), 110.26
(C12), 99.90 (C15), 80.52 (C2),
75.85 (C3), 74.52 (C4), 66.54 (C6),
63.96 (C5), 53.15 (C1), 51 (C9),
30.16, 27.74, 27.74, 20.34 (C13, C14, C15,
C17), 22.26 (C7). MS (ESI+):
m/z = 341.27 [M + H]+,
363.29 [M + Na]+.
32
Typical Procedure
for the Synthesis of Compounds 6-8
Compounds 3, 4, or 5 (1 equiv) and Ph3P (2 equiv)
were dissolved in a minimum amount of dry toluene. The mixture was
stirred under argon at r.t. DEAD (2 equiv, 2.56 mmol, 1.2 mL) was
added dropwise, and the mixture was stirred further 3 h. The crude
product was purified by chromatog-raphy on SiO2 (PE-Et2O,
7:3) to afford compounds 6, 7,
or 8 in 70% yield.
Compound 6: R
f
= 0.2
(PE-Et2O, 7:3); [α]D +5.86
(c 1, HCCl3, 25 ˚C). ¹H
NMR (400 MHz, acetone d
6
): δ = 7.42 (m,
2 H, Hc), 7.30 (m, 2 H, Hd), 7.23 (m, 1 H,
He), 4.43 (dd, J
3-4 = 2.5
Hz, J
3-2 = 8.0
Hz, H3), 4.25 (dd, J
4-3 = 2.7
Hz,
J
4-5 = 5.6
Hz, H4), 4.23 (dd, J
2-1 = 2.1
Hz, J
2-3 = 8.1
Hz, H2), ν0 = 3.99
(ABq, 2 H, νA = 4.13, νB = 3.85, Δν = 112.3
Hz, J
AB = 14.3
Hz, Ha), 3.85 (ddd, J
1-2 = 2.2
Hz, J
1-7b = 7.3
Hz, J
1-7a = 7.4
Hz, H1), 3.38 (dd, J
6a-5 = 6.1
Hz, J
6a-6b = 11.7
Hz, H6a), 3.33 (dd, J
6b-5 = 6.4
Hz, J
6b-5 = 11.8
Hz, H6b), 2.99 (dd, J
7a-1 = 7.7
Hz, J
7a-7b = 17.0
Hz, H7a), 3.00 (ddd, J
5-6a = 6.3 Hz, J
5-6b = 6.4
Hz, J
5-4 = 5.7
Hz, H5), 2.91 (dd, J
7b-1 = 7.2 Hz, J
7b-7a = 17.0
Hz, H7b), 1.61 (s, CH3), 1.38 (d, J = 0.4 Hz, CH3),
1.30 (s, CH3), 1.30 (s, CH3). ¹³C
NMR (100 MHz, acetone-d
6): δ = 143.17
(Cb), 130.49, 129.94 (C
ortho
/
meta
), 128.71 (C
para
), 120.32 (C8),
110.60 (C9), 101.23 (C12), 75.99 (C3),
73.64 (C4), 65.87 (C2), 63.77 (C6),
56.87 (Ca), 56.15 (C5), 53.49 (C1),
27.67, 27.25, 24.44, 22.68 (C10, C11, C13, C14),
19.81 (C7). MS (ESI+): m/z = 373.32 [M + H]+,
395.28 [M + Na]+,
411.18 [M + K]+,
767.57 [2 M + Na]+.
Compound 7: R
f
= 0.6
(PE-Et2O, 8:2); [α]D +6.52
(c 1, HCCl3, 25 ˚C). ¹H
NMR (400 MHz, acetone-d
6): δ = 4.38 (dd, J
3-4 = 26.0
Hz, J
3-2 = 8.0
Hz, H3), 4.26 (dd, J
4-3 = 2.6 Hz, J
4-5 = 5.6
Hz, H4), 4.15 (dd, J
2-1 = 2.2
Hz, J
2-3 = 8.0
Hz, H2), 3.78 (dd, J
6a-5 = 6.2
Hz, J
6a-6b = 11.7
Hz, H6a), 3.69 (ddd, J
1-2 = 2.2
Hz, J
1-7a = 7.7
Hz, J
1-7b = 8.4
Hz, H1), 3.56 (dd, J
6b-5 = 6.6
Hz, J
6b-6a = 11.7
Hz, H6b), 3.05 (q, J
5-4 =
J
5-6a = J
5-6b = 6.1
Hz, H5), 2.86-2.64 (m, 4 H, H7a,
H7b, H9a, H9b), (s, 3 H, CH3),
1.41-1.20 (m, 4 H, H10a, H10b, H11a,
H11b), 1.47, 1.36, 1.33, 1.30 (4 s, 12 H, H14,
H15, H17, H18). ¹³C NMR
(100 MHz, acetone-d
6): δ = 120.20
(C8), 110.46 (C13), 101.13 (C16),
75.97 (C3), 73.47 (C2), 65.69 (C4),
64.57 (C6), 57.07 (C5), 53.58 (C1),
52.66 (C9), 35.35 (C10), 27.60, 27.08, 24.47,
22.85 (C14, C15, C17, C18),
21.60 (C11), 19.81 (C7), 15.38 (C12).
MS (ESI+): m/z = 339.36 [M + H+],
361.26
[M + Na]+,
699.47 [2 M + Na]+.
Compound 8: R
f
= 0.28
(PE-Et2O, 8:2); [α]D +8.34
(c 1, HCCl3, 25 ˚C). ¹H
NMR (400 MHz, acetone-d
6): δ = 5.76 (dddd, J
10-11
trans
= 17.19
Hz, J
10-11
cis
= 10.07
Hz, J
10-9b = 7.99
Hz, J
10-9a = 4.40
Hz, H10), 5.15 (dtd, J
11
trans
-10 = 17.21 Hz, J = 2.03 Hz, J
11
trans
-11
cis
= 1.11
Hz, H11
trans
),
5.00 (dtd, J
10-11
cis
= 10.07
Hz, J = 1.88
Hz, J
11
cis
-9a = 1.87
Hz, J
11
cis
-11
trans
= 0.92
Hz, H11
cis
), 4.37
(dd, J
3-2 = 7.94
Hz, J
3-4 = 2.60 Hz,
H3), 4.25 (dd, J
4-5 = 5.27
Hz, J
4-3 = 2.60
Hz, H4), 4.17 (dd, J
2-3 = 7.95
Hz, J
2-1 = 2.12
Hz, H2), 3.78 (td, J = 8.17 Hz, J
1-2 = 1.94
Hz, J = 1.94
Hz, H1), 3.74 (dd, J
6a-6b = 11.82 Hz, J = 5.63 Hz,
H6a-6b), 3.60 (tdd, J
9a-9b = 14.88
Hz, J
9a-10 = 4.12
Hz, J
9a-11
cis
= 1.87
Hz, J = 1.87
Hz, H9a), 3.57 (dd,
J
6b-6a = 11.76
Hz, J = 5.85
Hz, H6a-6b), 3.26 (tdd, J
9b-9a = 14.88
Hz, J
9b-10 = 7.99
Hz, J = 1.04,
1.04 Hz, H9b), 2.99 (q, J
5-4 = 5.59
Hz, J
5-6a = 5.59
Hz, J
5-6b = 5.59
Hz, H5), 2.84 (d, J = 0.65
Hz, H7a), 2.82 (s, H7b), 1.50, 1.37, 1.34,
1.30 (4 d, 12 H, J = 0.58
Hz, H13, H14, H16, H17). ¹³C
NMR (100 MHz, acetone-d
6): δ = 140.93
(C10), 120.04 (C8), 116.88 (C11), 110.53
(C12), 101.04 (C15), 75.88 (C3),
73.75 (C2), 66.04 (C4), 64.51 (C6),
55.81 (C9), 55.67 (C5), 53.38 (C1),
28.07, 27.20, 24.50, 22.38 (C14, C13, C16,
C17), 19.77 (C7). MS (ESI+): m/z = 323.27 [M + H]+,
345.21 [M + Na]+,
361.20
[M + K]+.